Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations

Allovir's CEO, Diana Brainard, sold 1,533 shares of common stock on April 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On April 2, 2024, Diana Brainard, CEO of Allovir, Inc., sold 1,533 shares of Allovir's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $0.772, with individual transactions ranging from $0.7513 to $0.7801.
• Following the transaction, Brainard directly owns 812,536 shares of Allovir common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. The CEO sold shares to cover taxes, which is a common practice and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This particular filing reflects a common practice of selling shares to cover tax obligations associated with equity compensation.

Stakeholder Impact

• The sale of shares by the CEO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates